“Bimekizumab 3-Year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3 3b Trials”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s304. https://doi.org/10.25251/skin.8.supp.304.